Medical Devices Market Research Reports

SEARCH REPORTS

Medical Devices Market Research Reports & Consulting

Medical technology breakthroughs have led to a radical transformation in patient care by enabling a greater focus on clinical outcomes. Minimally invasive or non-invasive medical technologies, for instance, not only shorten recovery time but also lower medical costs. The growth of the markets for telemedicine and drug eluting stents also demonstrate the growing trend in medicine of using cutting-edge technology to enhance clinical outcomes. MarketsandMarkets tracks vital medical devices markets such as orthopedic devices, cardiovascular devices, surgical devices, therapeutic devices, mobility assist devices, self diagnostic devices, and neurostimulators.

Medical devices refer to a broad range of instruments, machines, implants, apparatuses, software, or other similar items that are specifically designed and manufactured for medical purposes. These devices are used in the prevention, diagnosis, treatment, or management of diseases, injuries, or disabilities in humans.

Medical devices can vary in complexity and function. They can be as simple as tongue depressors, thermometers, or bandages, or as advanced as robotic surgical systems, pacemakers, or imaging machines such as MRI (Magnetic Resonance Imaging) scanners.

The primary objective of medical devices is to improve the quality of patient care by providing accurate and reliable diagnostic information, delivering therapies, or assisting in medical procedures. They are often regulated by governmental bodies, such as the Food and Drug Administration (FDA) in the United States, to ensure their safety, effectiveness, and quality.

Medical devices play a crucial role in modern healthcare and are utilized in various settings, including hospitals, clinics, ambulatory care centers, and home healthcare. They are developed through rigorous research, design, testing, and manufacturing processes to meet specific medical requirements and comply with relevant regulations and standards.

Futuristic scope –

The field of medical devices is constantly evolving, and there are several futuristic trends and advancements that hold great potential for improving healthcare in the coming years. Here are some areas with exciting prospects:

Wearable Medical Devices: Wearable devices, such as smartwatches, fitness trackers, and biosensors, are already gaining popularity. In the future, these devices are expected to become more advanced, capable of monitoring a wide range of health parameters, including blood glucose levels, heart rhythm abnormalities, hydration levels, and more. They can provide real-time data and personalized feedback, enabling individuals to actively manage their health and allowing healthcare providers to deliver more precise care.
Telemedicine and Remote Monitoring: Telemedicine and remote patient monitoring have witnessed significant growth, especially during the COVID-19 pandemic. The integration of medical devices with telemedicine platforms will allow patients to receive remote consultations and continuous monitoring of their health conditions. For instance, wearable devices combined with artificial intelligence (AI) algorithms can detect early signs of health deterioration and alert healthcare professionals, enabling proactive interventions and reducing hospitalizations.
Robotics and Minimally Invasive Surgery: Robotic-assisted surgical systems have already revolutionized certain surgical procedures, offering increased precision and control to surgeons. As technology advances, we can expect more sophisticated robotic systems capable of performing complex surgeries with minimal invasiveness. These advancements may lead to shorter recovery times, reduced complications, and improved patient outcomes.
Implantable Devices and Artificial Organs: Implantable medical devices, such as pacemakers and cochlear implants, have been transforming the lives of individuals with chronic conditions. In the future, we may see the development of more advanced implantable devices, including artificial organs and neural interfaces, that can restore or enhance the functioning of specific body systems. These devices could greatly improve the quality of life for people with disabilities or organ failures.
Nanotechnology and Drug Delivery Systems: Nanotechnology has the potential to revolutionize drug delivery and improve targeted therapies. Nanoscale devices or nanoparticles can be engineered to deliver medications precisely to specific cells or tissues, enhancing their effectiveness while minimizing side effects. Additionally, nanosensors could be used for real-time monitoring of various biomarkers within the body, aiding in early disease detection and personalized treatment approaches.
Artificial Intelligence and Machine Learning: AI and machine learning algorithms have the potential to analyze vast amounts of medical data and assist healthcare professionals in diagnosis, treatment planning, and decision-making. These technologies can help identify patterns, predict outcomes, and provide personalized recommendations based on individual patient data. AI-powered medical devices and diagnostic tools can contribute to more accurate and efficient healthcare delivery.

It's important to note that while these futuristic possibilities hold tremendous promise, their successful implementation will require extensive research, rigorous testing, regulatory approvals, and careful consideration of ethical, privacy, and security aspects.

Merger & Acquisition –

Merger and acquisition (M&A) activities in the medical device industry involve the consolidation, integration, or purchase of medical device companies by other companies. These transactions are typically aimed at achieving strategic objectives, such as expanding product portfolios, entering new markets, gaining competitive advantages, or leveraging synergies.

M&A activities in the medical device sector can take various forms, including:

Horizontal M&A: This involves the merger or acquisition of companies operating in the same or similar areas of the medical device industry. It allows companies to expand their market share, eliminate competition, and achieve economies of scale. For example, a company specializing in orthopedic implants may acquire another orthopedic device manufacturer to broaden its product range and strengthen its market position.
Vertical M&A: Vertical integration occurs when a company acquires or merges with a supplier, distributor, or service provider within the medical device supply chain. This strategy aims to streamline operations, control costs, enhance supply chain efficiency, and improve overall business performance. For instance, a medical device manufacturer may acquire a contract manufacturing organization (CMO) to bring manufacturing capabilities in-house and gain greater control over production processes.
Diversification: Companies may engage in M&A activities to diversify their product offerings or enter new market segments. This strategy allows them to reduce reliance on a single product or market and mitigate risks. For example, a company specializing in cardiovascular devices may acquire a company with expertise in neurovascular devices to diversify its product portfolio and expand into a new therapeutic area.
Technology Acquisition: M&A transactions may occur to acquire innovative technologies or intellectual property rights that complement or enhance existing product lines. This strategy enables companies to stay competitive and drive product innovation. For instance, a company focused on diagnostic imaging may acquire a startup with breakthrough imaging technology to strengthen its product capabilities.
Geographic Expansion: M&A activities can facilitate entry into new geographic markets or enhance the global presence of a company. By acquiring companies with established distribution networks or market access in specific regions, companies can expand their reach and capture new customers. This strategy is particularly relevant for companies seeking international growth opportunities.

M&A transactions in the medical device industry are subject to regulatory scrutiny to ensure compliance with antitrust laws and to assess potential impacts on competition and patient welfare. Companies must also carefully consider factors such as financial valuation, integration challenges, cultural alignment, intellectual property rights, and regulatory compliance during the M&A process.

Overall, M&A activities in the medical device sector are driven by strategic objectives and aim to create synergies, drive growth, and enhance competitiveness in an evolving healthcare landscape.

Key segments in Medical Devices:

The medical device industry encompasses various segments that cater to different healthcare needs and specialties. Here are some key segments within the medical device industry:

Diagnostic Devices: Diagnostic devices are used to detect and diagnose medical conditions. This segment includes devices such as imaging systems (X-ray, MRI, CT scanners), ultrasound machines, blood analyzers, molecular diagnostic instruments, and point-of-care testing devices. These devices provide healthcare professionals with critical information for accurate diagnosis and treatment planning.
Therapeutic Devices: Therapeutic devices are designed to deliver treatments or therapies to patients. This segment includes devices such as implantable cardioverter-defibrillators (ICDs), pacemakers, insulin pumps, infusion pumps, nebulizers, ventilators, and dialysis machines. These devices aid in managing chronic conditions, delivering medications, providing respiratory support, and performing life-sustaining functions.
Surgical Devices: Surgical devices are used during surgical procedures to assist surgeons in performing operations. This segment includes devices such as surgical instruments (forceps, scalpels, retractors), electrosurgical devices, surgical lasers, robotic surgical systems, and surgical staplers. These devices enhance precision, minimize invasiveness, and improve surgical outcomes.
Monitoring Devices: Monitoring devices are used to track and measure physiological parameters of patients. This segment includes devices such as vital signs monitors, electrocardiographs (ECG/EKG), blood pressure monitors, glucose meters, pulse oximeters, sleep apnea monitors, and continuous glucose monitoring systems. These devices provide real-time data on a patient's vital signs, enabling healthcare professionals to monitor their condition and make informed decisions.
Rehabilitation and Assistive Devices: Rehabilitation and assistive devices are designed to aid individuals with disabilities or impairments in their daily activities. This segment includes devices such as prosthetics, orthotics, mobility aids (wheelchairs, walkers), hearing aids, visual aids, and assistive technology for communication and mobility. These devices enhance mobility, sensory functions, and overall quality of life for individuals with disabilities.
Implantable Devices: Implantable devices are surgically placed inside the body to restore or enhance specific bodily functions. This segment includes devices such as cardiac implants (pacemakers, defibrillators), neurostimulators, cochlear implants, artificial joints (hips, knees), and intraocular lenses. Implantable devices aim to improve patient health and function by replacing or augmenting damaged or impaired body parts.
Home Healthcare Devices: Home healthcare devices are designed for use in non-hospital settings, allowing patients to receive care and monitoring in the comfort of their homes. This segment includes devices such as home infusion pumps, home dialysis machines, portable oxygen concentrators, sleep apnea machines, and remote monitoring devices. Home healthcare devices promote patient independence, reduce hospital stays, and enable personalized care.

These segments represent a broad overview of the medical device industry, and there are numerous subcategories and specialized devices within each segment. Advances in technology and innovation continue to drive the development of new and improved medical devices across these segments, aiming to enhance patient care and improve healthcare outcomes.

subsegments in Medical Devices:

The medical device industry consists of numerous subsegments that focus on specific areas of healthcare and address specialized needs. Here are some subsegments within the key segments of medical devices:

Diagnostic Devices:

Imaging Devices: X-ray machines, magnetic resonance imaging (MRI) scanners, computed tomography (CT) scanners, ultrasound systems.
In vitro Diagnostic (IVD) Devices: Blood analyzers, molecular diagnostic instruments, immunoassay systems, point-of-care testing devices.
Diagnostic Imaging Contrast Agents: Contrast media used in imaging procedures to enhance visualization.

Therapeutic Devices:

Cardiac Devices: Implantable cardioverter-defibrillators (ICDs), pacemakers, cardiac monitors, cardiac resynchronization therapy devices.
Diabetes Management Devices: Insulin pumps, continuous glucose monitoring systems, blood glucose meters.
Respiratory Devices: Nebulizers, ventilators, continuous positive airway pressure (CPAP) machines.
Renal Devices: Dialysis machines, hemodialysis catheters, peritoneal dialysis systems.

Surgical Devices:

Minimally Invasive Surgical Devices: Laparoscopic instruments, endoscopes, robotic surgical systems.
Surgical Energy Devices: Electrosurgical devices, laser systems, ultrasonic dissectors.
Surgical Instruments: Forceps, scissors, retractors, scalpels, clamps, suturing devices.
Surgical Navigation Systems: Image-guided surgical systems, computer-assisted surgery devices.

Monitoring Devices:

Vital Signs Monitors: Devices for measuring and monitoring parameters such as heart rate, blood pressure, temperature, and respiratory rate.
Electrocardiographs (ECG/EKG): Devices for recording electrical activity of the heart.
Pulse Oximeters: Devices for measuring oxygen saturation levels in the blood.
Holter Monitors: Portable devices for continuous recording of ECG over a period of time.

Rehabilitation and Assistive Devices:

Prosthetics: Artificial limbs and prosthetic devices.
Orthotics: Devices such as braces, splints, and supports for musculoskeletal conditions.
Mobility Aids: Wheelchairs, walkers, crutches, canes.
Hearing Aids: Devices for individuals with hearing impairments.
Visual Aids: Glasses, contact lenses, magnifiers, visual prostheses.

Implantable Devices:

Cardiac Implants: Implantable pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices.
Neurostimulators: Implantable devices for neuromodulation and electrical stimulation for conditions such as chronic pain, Parkinson's disease.
Artificial Joints: Implantable hip, knee, shoulder, and other joint replacements.
Cochlear Implants: Implantable devices for individuals with severe hearing loss.
Intraocular Lenses: Artificial lenses used in cataract surgery to replace the natural lens.

Home Healthcare Devices:

Home Infusion Pumps: Devices for administering medication or fluids at home.
Home Dialysis Machines: Portable devices for performing dialysis at home.
Portable Oxygen Concentrators: Devices for providing oxygen therapy on the go.
Sleep Apnea Devices: Continuous positive airway pressure (CPAP) machines, oral appliances.
Remote Monitoring Devices: Devices for remote patient monitoring and telehealth services.

These subsegments represent specific areas of focus within each key segment of medical devices, catering to specialized medical needs and conditions. They reflect the diverse range of medical devices available to address various healthcare challenges and improve patient outcomes.

Medical Devices Ecosystem:

Manufacturers: Medical device manufacturers are responsible for designing, developing, and manufacturing medical devices. They conduct research, ensure regulatory compliance, and manage production processes to bring innovative and safe devices to the market.
Regulatory Authorities: Regulatory authorities, such as the FDA in the United States and the European Medicines Agency (EMA) in Europe, play a crucial role in overseeing the safety, efficacy, and quality of medical devices. They establish guidelines, review applications, and issue approvals or clearances to ensure devices meet regulatory standards.
Healthcare Providers: Healthcare providers, including hospitals, clinics, and healthcare professionals, utilize medical devices to diagnose, treat, and monitor patients. They rely on devices for accurate diagnostics, effective therapies, and improved patient care.
Distributors: Distributors act as intermediaries between manufacturers and healthcare providers, facilitating the supply chain and ensuring devices reach end-users. They handle logistics, inventory management, sales, and after-sales support.
Research and Development: Research and development (R&D) institutions, both within companies and academic settings, contribute to the advancement of medical devices. They conduct research, develop prototypes, and explore new technologies to drive innovation and improve medical device functionality.
Testing and Certification Organizations: Testing and certification organizations play a vital role in evaluating the safety, performance, and compliance of medical devices. They conduct testing, inspections, and audits to ensure devices meet quality standards and regulatory requirements.
Healthcare Professionals and Users: Healthcare professionals, including doctors, nurses, and technicians, play a critical role in the proper use and application of medical devices. They receive training, interpret device outputs, and provide care based on device-generated information. Patients and end-users also interact with medical devices for self-monitoring, home healthcare, and managing their health conditions.
Support Services: Support services, such as maintenance and repair providers, calibration laboratories, and technical support teams, assist in device upkeep, troubleshooting, and ensuring devices are functioning optimally.
Data Management and Analytics: With the rise of digital health, data management and analytics have become crucial in the medical devices ecosystem. Software platforms, cloud services, and analytics companies handle data collection, storage, analysis, and integration, enabling insights for personalized care, population health management, and clinical decision support.
Patients and Caregivers: Patients and caregivers are essential stakeholders in the medical devices ecosystem. They rely on devices to monitor health conditions, manage treatments, and enhance quality of life. Their feedback, adherence to device usage, and experience provide valuable insights for device improvement and innovation.

The medical devices ecosystem encompasses a wide range of stakeholders, each playing a distinct role in the development, deployment, and utilization of medical devices to improve healthcare outcomes and patient well-being.

Top players:

The medical device industry is home to several top players that have established themselves as leaders in the global market. Here are some of the prominent companies in the medical device sector:

Medtronic: Medtronic is a multinational medical device company based in Ireland. It offers a wide range of products across various therapeutic areas, including cardiac and vascular, minimally invasive therapies, restorative therapies, and diabetes management. Medtronic is known for its innovative devices such as pacemakers, defibrillators, insulin pumps, and surgical instruments.
Johnson & Johnson: Johnson & Johnson is a diversified healthcare company with a significant presence in the medical device industry. Its subsidiary, Ethicon, is a leader in surgical devices, including sutures, staplers, and energy devices. Johnson & Johnson's medical device portfolio also includes orthopedic implants, cardiovascular devices, diabetes care products, and vision care solutions.
Abbott Laboratories: Abbott is a global healthcare company that develops and manufactures a wide range of medical devices and diagnostics. Its product offerings include cardiovascular devices (e.g., stents, heart valves), diabetes care products (e.g., glucose monitoring systems, insulin pumps), diagnostic instruments, molecular diagnostics, and point-of-care testing devices.
Siemens Healthineers: Siemens Healthineers is a leading medical technology company focused on diagnostic imaging systems, laboratory diagnostics, and advanced healthcare IT solutions. The company's products range from X-ray, CT, and MRI systems to in vitro diagnostics equipment and clinical laboratory analyzers.
GE Healthcare: GE Healthcare, a division of General Electric, provides a comprehensive portfolio of medical devices, including diagnostic imaging systems, ultrasound machines, patient monitoring systems, and life support equipment. The company also offers healthcare IT solutions and services.
Stryker Corporation: Stryker is a global medical technology company specializing in orthopedics, medical and surgical equipment, and neurotechnology and spine products. It offers a wide range of innovative devices for joint replacement, trauma surgery, surgical navigation, and neurovascular interventions.
Becton, Dickinson and Company (BD): BD is a leading global medical technology company that develops and manufactures a diverse range of medical devices and solutions. The company's product offerings include injection and infusion systems, diagnostic systems, surgical instruments, and advanced bioprocessing technologies.
Boston Scientific Corporation: Boston Scientific is a renowned medical device company focused on areas such as cardiovascular interventions, rhythm management, urology and pelvic health, endoscopy, and neuromodulation. It develops and markets devices for procedures like coronary stenting, pacemakers, catheters, and endoscopic tools.
Zimmer Biomet Holdings: Zimmer Biomet is a global leader in musculoskeletal healthcare, specializing in orthopedic implants, surgical instruments, and advanced technologies for joint reconstruction, sports medicine, spine surgery, and dental applications.
Philips Healthcare: Philips Healthcare offers a wide range of medical devices and solutions, including imaging systems (such as CT and MRI), patient monitoring systems, respiratory care devices, and home healthcare solutions. The company focuses on integrating technology and data to improve patient outcomes and healthcare efficiency.

These companies have established strong market positions through their product portfolios, technological innovation, global presence, and commitment to advancing healthcare. However, it's important to note that the medical device industry is highly competitive, and there are several other notable players contributing to the advancement of medical technology.

High grown opportunities:

The medical device industry offers numerous high-growth opportunities driven by various factors such as technological advancements, increasing healthcare needs, and evolving market dynamics. Here are some key areas that present significant growth opportunities in the medical device sector:

Digital Health and Connected Devices: The integration of digital technologies and connectivity in medical devices is transforming healthcare delivery. Opportunities exist in the development of wearable devices, remote patient monitoring systems, mobile health applications, telemedicine platforms, and digital therapeutics. These technologies enhance patient engagement, enable real-time monitoring, and facilitate personalized healthcare delivery.
Minimally Invasive and Robotic-Assisted Surgery: Minimally invasive surgical techniques and robotic-assisted surgery have gained significant popularity due to their potential to reduce invasiveness, shorten recovery times, and improve surgical outcomes. The demand for advanced surgical instruments, robotic systems, and imaging technologies for minimally invasive procedures is expected to grow as more healthcare providers adopt these techniques.
Personalized Medicine and Point-of-Care Diagnostics: Advances in genomics, molecular diagnostics, and personalized medicine have created opportunities for the development of innovative diagnostic devices. Point-of-care testing devices, genetic testing platforms, and companion diagnostics are witnessing growth as they enable targeted treatments, improve disease management, and enhance patient outcomes.
Artificial Intelligence and Machine Learning: Artificial intelligence (AI) and machine learning (ML) technologies have the potential to revolutionize medical devices by improving diagnostic accuracy, predicting patient outcomes, and enabling real-time data analysis. AI-powered imaging systems, predictive analytics tools, and decision support systems are emerging as growth areas within the medical device industry.
Remote Monitoring and Home Healthcare: The shift towards patient-centered care and the aging population have fueled the demand for remote monitoring devices and home healthcare solutions. Remote patient monitoring systems, wearable health trackers, and home-based medical devices are expected to experience significant growth as they enable continuous monitoring, early intervention, and personalized care outside traditional healthcare settings.
Advanced Implantable Devices: The market for implantable medical devices, such as cardiac implants, neurostimulators, and orthopedic implants, continues to grow as the aging population increases and the demand for improved quality of life rises. Advancements in materials, biocompatibility, and design are driving the development of next-generation implantable devices with enhanced functionality and durability.
Emerging Markets: Emerging markets, particularly in Asia, Latin America, and Africa, offer substantial growth opportunities for medical device companies. Rising healthcare expenditures, increasing access to healthcare services, and expanding middle-class populations are driving demand for medical devices in these regions. Companies that can effectively navigate regulatory landscapes, adapt to local needs, and provide affordable solutions have the potential for significant growth in emerging markets.

It's important to note that the medical device industry is subject to regulatory requirements and challenges related to reimbursement, intellectual property, and market competition. Companies that can navigate these complexities while addressing evolving healthcare needs stand to benefit from the high-growth opportunities within the medical device sector.

Challenges in Medical Devices Industry:

The medical device industry faces several challenges that impact its growth, innovation, and market dynamics. Here are some key challenges in the medical device industry:

Regulatory Compliance: Medical devices are subject to strict regulations and standards to ensure safety, efficacy, and quality. Obtaining regulatory approvals, navigating complex compliance requirements, and managing post-market surveillance can be time-consuming and costly for medical device companies.
Reimbursement and Pricing Pressures: Reimbursement policies and pricing pressures pose challenges for medical device manufacturers. Negotiating reimbursement contracts with healthcare payers and demonstrating cost-effectiveness and clinical value are essential to gain market access and sustain profitability.
Technological Advancements and Innovation: The medical device industry is highly competitive, and staying at the forefront of technological advancements is critical. Companies face the challenge of continuously innovating and developing new devices with enhanced features, improved outcomes, and cost-effectiveness.
Intellectual Property Protection: Protecting intellectual property (IP) rights is crucial for medical device companies. The industry is susceptible to patent disputes, infringement issues, and challenges in safeguarding proprietary technologies. Ensuring strong IP protection and defending against potential legal threats are ongoing challenges.
Market Access and Global Expansion: Expanding into new markets, especially international markets, can be challenging due to variations in regulatory requirements, cultural differences, and market dynamics. Establishing distribution networks, complying with local regulations, and understanding market needs are critical for successful market access and expansion.
Cost and Time to Market: Developing and commercializing medical devices involve significant investments in research and development, clinical trials, and manufacturing. Long development timelines, cost overruns, and delays in obtaining regulatory approvals can impact companies' ability to bring products to market in a timely and cost-effective manner.
Healthcare System Adoption: Healthcare systems and providers may be slow to adopt new technologies and devices due to factors such as budget constraints, resistance to change, and concerns about reimbursement. Demonstrating clinical evidence, cost-effectiveness, and addressing barriers to adoption are essential for widespread acceptance and adoption of medical devices.
Data Security and Privacy: With the increasing use of connected devices and digital health technologies, data security and privacy have become critical concerns. Protecting patient data, ensuring cybersecurity measures, and complying with data privacy regulations present ongoing challenges for medical device companies.
Supply Chain Disruptions: Disruptions in the global supply chain, such as raw material shortages, transportation issues, and geopolitical events, can impact the production and availability of medical devices. Ensuring supply chain resilience and mitigating risks are vital to maintain uninterrupted device availability.
Healthcare Cost Containment: Healthcare systems globally are under pressure to contain costs. Medical device companies need to address the cost-effectiveness of their devices, demonstrate economic value, and work collaboratively with healthcare providers to meet cost containment objectives.

Navigating these challenges requires strategic planning, collaboration with stakeholders, investment in research and development, and a deep understanding of market dynamics. Companies that can effectively address these challenges have a better chance of succeeding in the competitive medical device industry.

High CAGR geography:

The Compound Annual Growth Rate (CAGR) of the medical device industry can vary across different geographies due to factors such as population demographics, healthcare infrastructure, regulatory environments, and economic growth. While it is difficult to predict the precise CAGR for specific geographies, there are regions that have shown potential for high growth in the medical device sector. Here are a few geographies that have been identified as having a high CAGR for medical devices:

Asia-Pacific: The Asia-Pacific region has witnessed significant growth in the medical device market. Countries like China, India, and Japan have large populations with increasing healthcare needs. Rising disposable incomes, improving healthcare infrastructure, and government initiatives to enhance healthcare access have contributed to the growth of the medical device sector in this region.
Latin America: Latin America is another geography with a high growth potential for medical devices. Countries such as Brazil, Mexico, and Argentina have expanding middle-class populations and increasing healthcare expenditures. The demand for medical devices in areas such as diagnostic imaging, surgical instruments, and cardiovascular devices is expected to grow in this region.
Middle East and Africa: The Middle East and Africa region is experiencing rapid growth in healthcare infrastructure and spending. Countries like Saudi Arabia, United Arab Emirates, South Africa, and Kenya are investing in modernizing healthcare facilities and expanding access to medical services. This creates opportunities for medical device companies, particularly in areas such as diagnostic imaging, patient monitoring, and surgical equipment.
North America: Despite being a mature market, North America, especially the United States, continues to offer growth opportunities in the medical device sector. Technological advancements, increasing chronic disease prevalence, and a focus on value-based healthcare are driving the demand for innovative medical devices and technologies in this region.
Europe: Europe remains a significant market for medical devices, with countries like Germany, France, and the United Kingdom being major contributors. The region's aging population, favorable reimbursement policies, and a focus on healthcare modernization create opportunities for medical device companies, particularly in areas such as implantable devices, diagnostic imaging, and in vitro diagnostics.

see less

Market Reports

Dental Biomaterials Market by Type (Metallic (Titanium, Stainless Steel, Chromium Alloy, Amalgam, Gold), PFM, Ceramic, Bone Graft, Polymer Biomaterials), Application (Implantology, Prosthetic, Orthodontic), End User & Region - Global Forecasts to 2023

The dental biomaterials market is projected to reach USD 9.6 billion by 2023, at a CAGR of 7.4%. The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth. The prominent players in the dental biomaterials market include Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland).
- Published: January 2019
- Price: $ 4950
- TOC Available:
Hemostasis Valve Market by Type (Hemostasis Valve Y Connector, Double Y Connector Hemostasis Valve, One Handed), Application (Angioplasty, Angiography), End User (Hospitals), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023

The hemostasis valves market is projected to grow from USD 132 million in 2018 to USD 175 million by 2023, at a CAGR of 5.8% during the forecast period. Growth in the hemostasis valves market is mainly driven by the increasing number of interventional procedures. Merit Medical Systems (US), Abbott (US), Teleflex Incorporated (US), Boston Scientific (US), B. Braun Melsungen (Germany), DeRoyal Industries, Inc. (US), Freudenberg Medical (US), Scitech (Brazil), and Argon Medical (US).
- Published: January 2019
- Price: $ 4950
- TOC Available:
Neonatal Care Equipment and Fetal (Labor & Delivery) Market - (Ultrasound, Doppler, Fetal Monitors (Intrapartum, Antepartum), Warmer, Incubator, Pulse Oximeter, Phototherapy Devices, Ventilator, MRI, CPAP, Capnograph, Resuscitator)-Global Forecast to 2023

The fetal and neonatal care equipment market is projected to grow USD 8.4 billion by 2023, at a CAGR of 5.7% during the forecast period. Growth in the fetal and neonatal care equipment market is mainly driven by the rise in number of preterm and low-weights birth infants, growing number of NICU admissions, and increased awareness of neonatal and fetal care across developing nations.GE Healthcare (U.K.), Philips Healthcare (Netherlands), Drägerwerk AG & Co. KGaA (Germany), Medtronic plc (Ireland), and Masimo Corporation (U.S.).
- Published: December 2018
- Price: $ 4950
- TOC Available:
Surgical Snare Market by Usability (Singel Use, Reusable), Application (GI Endoscopy, Laparoscopy, Urology Endoscopy, Gynecology Endoscopy, Arthroscopy, Bronchoscopy, Mediastinoscopy, Laryngoscopy), End User (Hospital, ASC) & Region - Global Forecasts to 2023

The surgical snare Market is projected to USD 1,255 million by 2023, at a CAGR of 4.8%. The major driving factors in the surgical snares market are increasing number for colon polypectomy procedures, growth of the endoscopic ambulatory surgical centers, and a rising preference for minimally invasive surgeries are the key factors. The major surgical snares providers include Olympus (Japan), Boston Scientific (US), Cook Medical (US), CONMED Corporation (US), Medline Industries (US), Medtronic (Ireland), Steris (US), Merit Medical Systems (US), and Avalign Technologies (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
Veterinary X-ray Market by Technology (Direct, Computed, Film), Type (Digital, Analog), Mobility (Fixed, Portable), Animal (Companion, Large Animal), Application (Trauma, Oncology, Dental), End User (Clinic, Hospital) - Forecasts to 2023

The veterinary X-ray market is projected to reach USD 872 million by 2023, at a CAGR of 6.4%. Rising animal health expenditure and growing demand for pet insurance, increasing number of veterinary practitioners in developed regions, and growth in the companion animals market are the primary drivers for the veterinary X-ray market during the forecast period. The prominent players in the veterinary X-ray market are IDEXX (US), Fujifilm (Japan), Onex Corporation (Canada), Sedecal (Spain), Agfa-Gevaert (Belgium), Sound Technologies (US), Fujifilm Holdings Corporation (Japan), Canon, Inc (Japan), Examion (Germany), Konica Minolta (US), DRE Veterinary (US), and Heska Corporation (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
Pacemakers Market by Implantability (External), Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), Type (Conventional, MRI Compatible), End User (Hospitals and Cardiac Centers, Ambulatory Surgical Center) - Global Forecasts to 2023

The pacemakers market is projected to reach USD 4.9 billion by 2023, at a CAGR of 2.0%. Growth in this market is driven by increasing prevalence of cardiovascular diseases and technological advancements in devices. Major vendors in the pacemakers market include Medtronic (Ireland), Abbott (US), and Boston Scientific (US), BIOTRONIK (Germany), LivaNova (UK), OSCOR (US), Pacetronix (India), MEDICO (Italy), Osypka Medical (Germany), and Lepu Medical (China).
- Published: November 2018
- Price: $ 4950
- TOC Available:
Pedicle Screw System Market by Product Type (Monoaxial & Polyaxial Pedicle Screw), Surgery (Open Surgery, Minimal Invasive Surgery), Indication (Spinal Deformities, Spinal Trauma), Application (Thoracolumbar, Cervical Fusion) - Global Forecast to 2023

The global pedicle screw systems market is expected to reach USD 724.23 million by 2023 from USD 538.64 million in 2018, at a CAGR of 6.1%. The major factors driving the growth of this market are the increasing incidence of spinal cord injuries, the growing preference for minimally invasive surgeries, and a rising geriatric population. Key players in the pedicle screw systems market include DePuy Synthesis (US), Globus Medical (US), Zimmer Biomet (US), B. Braun (US), Medtronic (Ireland), and Stryker (US).
- Published: October 2018
- Price: $ 4950
- TOC Available:
Flexible & Semi-rigid Ureteroscopy Market by Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes), Application (Urolithiasis, Urinary Stricture, Kidney Cancer), End User (ASCS, Hospitals), and Region (US, Canada, Asia, Europe) - Global Forecast to 2023

The flexible & semi-rigid ureteroscopy market is expected to reach USD 1,054.1 million by 2023 from USD 809.6 million in 2018, at a CAGR of 5.4%. The high incidence of urolithiasis across the globe is a major factor driving the growth of this market. The rapidly increasing geriatric population, technological advancements in devices, and improving hospital infrastructures are the other major factors that are expected to support the growth of the flexible & semi-rigid ureteroscopy market in the coming years. Some of the major players operating in this market are Olympus (Japan), Stryker (US), Boston Scientific (US), KARL STORZ (Switzerland), Richard Wolf (Germany), ELMED Medical Systems (Turkey), Rocamed (France), Maxer Endoscopy (Germany), ProSurg (US), and Vimex Endoscopy (Poland). To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the Industrial Gearbox market. These players include Siemens AG (Germany), Bonfiglioli Italia S.P.A (Italy), Bondioli & Pavesi (Italy), Sew-Eurodrive (Germany), and Dana Brevini (Italy).
- Published: September 2018
- Price: $ 4950
- TOC Available:
Energy Efficient Glass Market by Coating (Hard Coat, Soft Coat), Glazing (Single Glazing, Double Glazing, Triple Glazing), Application (Building & Construction, Automotive, Solar Panel), and Region - Global Forecast to 2023

The global energy efficient glass market is estimated to be USD 25.11 billion in 2018 and is projected to reach USD 32.02 billion by 2023, at a CAGR of 5.0% between 2018 and 2023. The increased demand for energy efficient glass in the building & construction, automotive, and solar panel industries is expected to drive the energy efficient glass market.Companies such as Saint-Gobain S.A. (France), Nippon Sheet Glass Co., Ltd. (Japan), AGC Inc. (Japan), SCHOTT AG (Germany), Guardian Glass, LLC. (US), Sisecam Group (Turkey), and Vitro Architectural Glass (US) are the leading players in the energy efficient glass market
- Published: September 2018
- Price: $ 4950
- TOC Available:
Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023

The hemodynamic monitoring systems market is projected to reach USD 1,167.4 million by 2023, at a CAGR of 6.4% during the forecast period. The growth of this market is primarily driven by factors such as the technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems, influx of VC funding, and the rising prevalence of cardiovascular diseases & diabetes. The key players in the global hemodynamic monitoring systems market are Edwards Lifesciences Corporation (US), PULSION Medical Systems SE (Germany), LiDCO Group plc (UK), Cheetah Medical (Israel), Deltex Medical Group Plc. (UK), ICU Medical (US), Osypka Medical GmbH (Germany), CareTaker Medical (US), CNSystems (Austria), NI Medical (Israel), and Uscom (Australia).
- Published: August 2018
- Price: $ 4950
- TOC Available:
Trocars Market by Product (Disposable, Reusable, Reposable), Tip (Bladeless Trocars, Bladed Trocars, Blunt Trocars, Optical), Application (General Surgery, Urology, Pediatric, Gynecological Surgery), End User (Hospitals) - Global Forecast to 2023

The global trocars market is expected to reach USD 763.2 million by 2023, at a CAGR of 7.2%. The major factors driving the growth of this market are the increasing prevalence of cancer and hernia and growing preference for minimally invasive surgery. Key players in the trocars market include Medtronic (Ireland), Ethicon (US), B. Braun (Germany), Applied Medical (US), Cooper Companies (US), Teleflex (US), ConMed (US), LaproSurge (UK), Purple Surgical (UK), and GENICON (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
Breast Cancer Liquid Biopsy Market by Circulating Biomarkers, Region, End User, Investments, Market Dynamics, Platform Comparison (NGS, PCR), Competitive Landscape (Acquisition, Mergers, Collaboration, Competitive technology) & Geography

The global breast cancer liquid biopsy market is projected to grow at a CAGR of 23.1%. Factors such as increasing prevalence of breast cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancements to augment market revenues, rising emphasis on personalized medicine in clinical practice, and increased funding for liquid biopsy R&D are driving the growth of the breast cancer liquid biopsy market. The key players in the global breast cancer liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
Bowel Management Systems Market by Product (Irrigation Systems, Nerve Modulation Devices, Colostomy Bags, and Accessories), Patient Type (Adult and Pediatric), End User (Home Care and Hospitals, Ambulatory Surgery Center) - Global Forecast to 2023

The global bowel management systems market is projected to reach USD 2.07 billion by 2023, at a CAGR of 3.5%. Growth in the bowel management systems market is mainly driven by factors such as the expanding target patient population, the rapidly growing geriatric population, availability of technologically advanced bowel management products, and the favorable reimbursement scenario in developed countries. Some of the major players operating in the bowel management systems market are Coloplast (Denmark), Medtronic (Ireland), 3M (US), B. Braun (Germany), C.R. Bard (US), Consure Medical (India), Cogentix Medical (US), Aquaflush Medical Limited (UK), Axonics Modulation Technologies (US), ConvaTec (UK), Hollister (US), MBH-International A/S (Denmark), Mederi Therapeutics Inc. (US), Welland Medical limited (UK), and Wellspect HealthCare (Sweden).
- Published: July 2018
- Price: $ 4950
- TOC Available:
Artificial Tendons and Ligaments Market by Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, Spine Injuries, and Hip Injuries), and Region (North America, Europe, Asia Pacific, Rest of the World) - Global Forecasts to 2023

The global artificial tendons and ligaments market is projected to reach USD 35.0 million by 2023, at a CAGR of 13.6%. The growth of this market is primarily driven by factors such as the increasing incidence of sports injuries, growing number of initiatives to increase the awareness about artificial tendons and ligaments, increasing research activities on artificial tendons and ligaments, increasing preference for minimally invasive surgeries, benefits of artificial tendons and ligaments, and the issues related to the use of orthobiologics. The key players in the global artificial tendons and ligaments market are LARS (France), Neoligaments (UK), Cousin Biotech (France), Orthomed S.A.S. (France), FX Solutions (France), Shanghai PINE&POWER Biotech (China), and Mathys AG Bettlach (Switzerland).
- Published: July 2018
- Price: $ 4950
- TOC Available:
Veterinary Endoscopy Market by Product Type (Flexible, Videoscope, Fibreoptic, Rigid), Procedure (Bronchoscopy, Laparoscopy, Gastroduodenoscopy, Colonoscopy, Rhinoscopy), Animal (Companion, Large), End User (Hospitals, Clinics) - Global Forecasts to 2023

The global veterinary endoscopy market is expected to reach USD 219.0 million by 2023, at a CAGR of 6.5%. The market growth is primarily driven by the growing pet population, increasing number of pet health insurance, and advanced applications of veterinary endoscopes. Key players in the veterinary endoscopy market include KARL STORZ (Germany), Olympus (Japan), Fujifilm (Japan), Eickemeyer (Germany), B. Braun (Germany), STERIS (UK), Endoscopy Support Services (US), Biovision Veterinary Endoscopy (US), Welch Allyn (US), and Dr. Fritz (Germany).
- Published: July 2018
- Price: $ 4950
- TOC Available:
Dental Sterilization Market Growth by Product (Sterilization Equipment (high temperature, Low temperature), Ultrasonic Cleaner, Washer Disinfector, Surface Disinfectant, Instrument Disinfectant, Lubricant, Cleaning Solutions), End User - Global Forecast to 2023

The global dental sterilization market is projected to reach USD 1.48 Billion by 2023, at a CAGR of 6.6% during the forecast period. The prominent players in the dental sterilization market are Getinge (Sweden), Midmark (US), SciCan (Canada), Tuttnauer (US), Planmeca (Finland), DENTSPLY Sirona (US), Danaher (US), Matachana (Spain), A-dec (US), W&H (Austria), Hu-Friedy (US), and NAKANISHI (Japan). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the dental sterilization market.
- Published: June 2018
- Price: $ 4950
- TOC Available:
Dental Surgical Instruments Market by Product (Handheld Instruments, Laser, Dental Handpiece, Ultrasonic Instruments, Consumables), Therapeutic Area (Restorative Dentistry, Orthodontics), Patient Care Setting (Clinic, Hospital) - Global Forecast to 2023

The global dental surgical instruments market is projected to reach USD 5.96 billion by 2023 from USD 4.48 billion in 2018, at a CAGR of 5.9%. Factors such as the rising incidence of dental diseases, growing demand for cosmetic dentistry, increasing number of dental practitioners and dental clinics, and growing dental expenditure are expected to drive market growth during the forecast period. The key players in the global dental surgical instruments market are DENTSPLY Sirona Inc. (US), Danaher Corporation (US), 3M Company (US), COLTENE Holding AG (Switzerland), Brasseler USA, A-dec, Inc. (US), Hu-Friedy Manufacturing Company, LLC (US), Integra LifeSciences Holdings Corporation (US), NAKANISHI Inc. (Japan), BIOLASE, Inc. (US), The Yoshida Dental Mfg. Co., Ltd. (Japan), Helmut Zepf Medizintechnik GmbH (Germany), Prima Dental Manufacturing Ltd. (UK), B. Braun Melsungen AG (Germany), AMD Lasers (US), and CAO Group, Inc. (US).
- Published: June 2018
- Price: $ 4950
- TOC Available:
Angiography Equipment Market by Product (Angiography Systems, Catheters, Guidewire, Balloons, Contrast Media), Technology (X-Ray, CT, MRA), Procedure (Coronary, Endo, Neuro), Application (Diagnostic, Therapeutic), Patient Care Setting - Global Forecast to 2023

The angiography equipment market is projected to reach USD 13.06 Billion by 2023, at a CAGR of 5.0%. The growth in this market is attributed to the high prevalence of diseases such as cancer and CVDs, increasing product approvals for advanced angiography techniques in the market, the large number of ongoing research activities, growing government and public-private investments, increasing number of awareness programs, and rising adoption of angiography devices due to a large number of angiography procedures performed across the globe. The key players in the angiography equipment market are GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Canon Corporation (Japan), Boston Scientific Corporation (US), Cordis (a Cardinal Health Company, US), Shimadzu Corporation (Japan), Medtronic (Ireland), Angiodynamics (US), B. Braun Melsungen (Germany), and Abbott Laboratories (US).
- Published: June 2018
- Price: $ 4950
- TOC Available:
Lithotripsy Devices Market by Type (ESWL, Intracorporal (Laser, Electrohydraulic, Mechanical, Ultrasonic Lithotripsy)), Application (Kidney, Ureteral, Bile Duct & Pancreatic Stones), End User (Hospital), Procedures - Global Forecast to 2023

The global lithotripsy devices market is expected to reach USD 1.76 Billion by 2023, at a CAGR of 4.5%. Growth in this market is propelled by the increasing incidence of urolithiasis and technological advancements in lithotripsy devices. Some of the major players in the lithotripsy devices market are Siemens AG (Germany), Boston Scientific (US), Dornier MedTech (Germany), Olympus America (Japan), DirexGroup (Germany), and Richard Wolf (Germany). Key companies in the Lubricating Oil Additives market include Afton Chemical (US), Chevron Oronite (US), BASF (Germany), Evonik Industries (Germany), Lubrizol Corporation (US), and Lanxess (Germany).
- Published: June 2018
- Price: $ 4950
- TOC Available:
Cerebrospinal Fluid Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022

The global cerebrospinal fluid management market is projected to reach USD 1.56 Billion by 2022 from an estimated USD 1.26 Billion in 2017, at a CAGR of 4.4% during the forecast period. The growth of this market is majorly driven by factors such as the growing geriatric population and the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures. The key players in the global cerebrospinal fluid (CSF) management market are Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical Incorporated (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).
- Published: May 2018
- Price: $ 4950
- TOC Available:
Laparoscopic and Open Hernia Mesh Repair Surgery Market by Mesh Fixator (Glue And Tack Applicators), Country (US, Canada, Germany, France, UK, Italy, Spain, Japan, China, and India)

The laparoscopic repair surgery market is projected to grow at a CAGR of 2.1%. The increasing adoption of mesh in Hernia Repair surgeries, rising geriatric population, new product developments, and efficient reimbursement system in developed countries are the major factors driving the growth of the hernia mesh repair surgery market during the forecast period. The major players in the hernia mesh repair surgery market profiled in this report are Medtronic (Ireland), Johnson & Johnson (US), B. Braun (Germany), C. R. Bard (US), and W.L. Gore (US).
- Published: May 2018
- Price: $ 4950
- TOC Available:
Plastic Surgery Instruments Market by Type (Handheld (Forceps, Needle Holder, Scissors, Retractor), Electrosurgery (Bipolar, Monopolar)), Procedure (Cosmetic (Breast Augmentation, Face, Head, Extremities), Reconstructive), End User - Global Forecast to 2023

The global plastic surgery instruments market is projected to reach USD 1,479.0 Million by 2023, growing at a CAGR of 8.1%. Prominent players in the plastic surgery instruments market include Sklar Surgical Instruments (US), KLS Martin Group (Germany), Integra LifeSciences Corporation (US), Tekno-Medical Optik-Chirurgie GmbH (Germany), KARL STORZ GmbH & Co. KG (Germany), Zimmer Biomet (US), B. Braun Melsungen AG (Germany), BMT Medizintechnik GmbH (Germany), Anthony Products, Inc. (US), Bolton Surgical Ltd. (UK), Surgicon Pvt. Ltd. (Pakistan), and Blink Medical (UK).
- Published: May 2018
- Price: $ 4950
- TOC Available:
Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) & Geography

The global biomarker technologies market is projected to grow at a CAGR of 9.7%. The key players in the biomarker technologies market are Thermo Fisher Scientific (US), Agilent Technologies (US), Roche (Switzerland), Danaher Corporation (US), Waters Corporation (US), Shimadzu Corporation (Japan), and Bio-Rad Laboratories (US).
- Published: May 2018
- Price: $ 15000
- TOC Available:
EMEA 3D CBCT/Cone Beam CT Systems Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontic, Endodontic) and Non-Dental (Radiology, ENT)), End User (Hospitals and Clinics, Diagnostic Centres) - Forecast to 2023

The EMEA 3D CBCT systems market is projected to reach USD 300.4 Million by 2023 from USD 194.3 Million in 2018, at a CAGR of 9.0%. The growing number of dentists is one of the major drivers for the growth of the dental CBCT market in this region. This increase, along with the subsequent establishment of new clinics and rising government spending on healthcare, has contributed to a growing demand for dental equipment like CBCT systems. The key players in the EMEA 3D CBCT systems market are Danaher Corporation (US), DENTSPLY SIRONA (US), Carestream Dental (US), Planmeca Group (Finland), VATECH (South Korea), CEFLA (Italy), J. MORITA CORPORATION (Japan), ACTEON GROUP (France), Asahi Roentgen (Japan), and Genoray (South Korea).
- Published: May 2018
- Price: $ 4950
- TOC Available:
Angiographic Catheters Market by Application (Coronary, Endovascular, Neurology and Oncology), Geography (North America, Europe, Asia Pacific and Row), End-User Analysis (Reusage Scenario, Purchase Pattern) and Competitive Scenario - Global Forecast to 2022

Angiographic catheters market is expected to reach USD 1,402.8 million by 2022 from USD 922.1 million in 2016 and, at a CAGR of 7.4%. The base year for this study is 2016 and the forecast period is 2017–2022. Increasing number of Cath labs in APAC, incidences of CVDs and preference for minimally invasive surgeries are few of the reasons for the growth of this market
- Published: April 2018
- Price: $ 4950
- TOC Available:
Occlusion Devices Market by Product (Occlusion Balloon, Stent Retriever, Suction Device, Coil Embolization, Liquid Embolics), Application (Cardiology, Neurology, Peripheral Vascular, Urology, Oncology, Gyno), End User - Global Forecasts to 2023

The global occlusion devices market is projected to reach USD 3.55 Billion by 2023, at a CAGR of 5.3%. The growth witnessed by occlusion devices is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for occlusion devices across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Medtronic (Ireland), Terumo (Japan), Stryker Corporation (US), and Penumbra (US). Other prominent players present in this market are Abbott (US), Cardinal Health (US), B. Braun (Germany), Asahi Intecc (Japan), C.R. Bard (US), Cook Group (US), Angiodynamics (US), and Acrostak (US).
- Published: April 2018
- Price: $ 4950
- TOC Available:
Surgical Drapes and Gowns Market by Type (Drapes (Cardiovascular, General Surgery, C- Section, Lithotomy, Laparoscopy, Ophthalmic), Gown (Standard, Reinforced, High-Performance)), Utility (Reusable, Disposable), End User (Hospital) - Global Forecasts to 2023

The global surgical drapes market is expected to reach USD 3.14 Billion by 2023, at a CAGR of 4.9%. Major industry players launched innovative products to maintain and improve their position in the surgical drapes and gowns market. Cardinal Health (US), 3M (US), Mölnlycke Health Care (Sweden), Halyard Health (US), Thermo Fisher Scientific Inc. (US), Steris plc (US), and Paul Hartmann AG (Germany) have been identified as the key players in this market.
- Published: April 2018
- Price: $ 4950
- TOC Available:
Neuroendoscopy Market by Product (Rigid (Videoscope, Fiberscope), Flexible endoscope), Usability (Reuse and Disposable), Application (Transnasal, Intraventricular, and Transcranial), Region (North America, Europe, Asia) & Geography

The global neuroendoscopy devices market is expected to grow at a CAGR of 5.1%. Factors such favorable government initiatives, rising prevalence of neurological disorders, and benefits of neuroendoscopic surgery over conventional brain surgery are driving the growth of this market. The report segments the global neuroendoscopy devices market into product, application, usability, and region. The neuroendoscopy devices market includes various small and large players. Key players in this market are KARL STORZ (Germany), B.Braun Aesculap (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hawk (China), Machida (Japan), Tonglu Wanhe Medical (China), Schindler (Germany), Clarus (US), LocaMed (UK), and Visionsense (US).
- Published: April 2018
- Price: $ 4950
- TOC Available:
Urgent Care Center Market by Service (Acute Illness Treatment, Trauma/Injury Treatment, Physical Examination, Immunization & Vaccination), Ownership (Corporate Owned, Physician Owned, Hospital Owned), and Region - Global Forecasts to 2023

The global urgent care center market is projected to reach USD 25.93 Billion by 2023, at a CAGR of 5.3% during the forecast period. The growth of this market is driven by factors such as growing investments in urgent care, increasing geriatric population, strategic developments between urgent care providers and hospitals, and affordable care and shorter waiting periods offered by urgent care centers. Concentra (US), MedExpress (US), American Family Care (US), NextCare Holdings (US), and FastMed Urgent Care (US) are the key players in the urgent care center market. Other players involved in this market are CityMD (US), CareNow Urgent Care (US), GoHealth Urgent Care (US), HCA Healthcare UK (UK), Columbia Asia Hospitals (India), International SOS (China), and St. Joseph's Health Care London (Canada).
- Published: March 2018
- Price: $ 4950
- TOC Available:
Automated blood Tube Labeler & Specimen Transport Box Market – By End User (Hospitals, Diagnostic Center, Skilled Nursing Facility, Long Term Acute Care Facilities), Specimen Transport Box Type (Traditional Boxes, Smart Transportation Boxes) & Geography

The automated blood tube labeler market is projected to grow at a CAGR of 6.8% during the forecast period. The market is dominated by players such as Techno Medica (Japan), Kobayashi Create (Japan), and Inpeco (Switzerland). The major players in specimen transport box market include Sonoco Product Company (US), Greiner Holding (Austria), and Alifax Holdings (Italy).
- Published: March 2018
- Price: $ 4950
- TOC Available:
Transradial Access Market by Product (Catheters, Guidewires, Sheath and Sheath Introducers), Application (Administration of Medicine and Administration of fluids), End User (Hospitals, Clinics & Ambulatory Centres) - Global Forecast 2022

The transradial access devices market is projected to reach USD 2.18 Billion by 2022 from USD 1.52 Billion in 2017, at a CAGR of 7.5%. The prominent players include Becton, Dickinson and Company (US) and Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic (Ireland), Merit Medical System, Inc. (US), Boston Scientific (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), and OSCOR Inc. (US).
- Published: March 2018
- Price: $ 4950
- TOC Available:
Colposcopy Market by Instrument Type (Optical, Digital), Portability (Fixed, Portable, Handheld), Application (Cervical Cancer Diagnosis, Physical Examination), End User (Hospitals, Clinics, Diagnostic Centres), and Region - Global Forecasts to 2023

The global colposcopy market is projected to reach USD 740.1 Million by 2023, at a CAGR of 6.8%. Market growth can largely be attributed to factors such as the heavy burden of cervical cancer, the rapidly growing geriatric population, and technological advancements in colposcopy. Increasing awareness about gynecological diseases and the emerging Asian markets are expected to present a wide array of growth opportunities for players in the market. Key players in the Colposcopy market include DySIS (US), CooperSurgical (US), Atmos (Germany), Olympus (Japan), Karl Kaps (Germany), McKesson (US), Danaher (US), and Carl Zeiss (Germany).
- Published: March 2018
- Price: $ 4950
- TOC Available:
Endoscopic Vessel Harvesting Market by Product (EVH systems, Endoscope, Accessories), Usability (Disposable, Reusable), Vessel (Saphenous Vein, Radial Artery), Application (Coronary Artery Disease, Peripheral Artery Disease) - Global Forecast to 2022

The global endoscopic vessel harvesting market is projected to reach USD 504.8 Million by 2022 from an estimated USD 420.5 Million in 2017, at a CAGR of 3.7% during the forecast period. The growth of this market is majorly driven by factors such as the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population. The key players in the global endoscopic vessel harvesting market are Getinge (Sweden), Terumo (Japan), LivaNova (UK), Saphena Medical (US), KARL STORZ (Germany), Cardio Medical (Germany), and Medical Instruments Spa (Italy).
- Published: March 2018
- Price: $ 4950
- TOC Available:
Cranial Fixation & Stabilization Systems Market by Product (Screw, Mesh, Skullclamp, Horseshoe Headrest, Accessories, Adaptor, Arms, Base units), Material (Nonresorbable, Resorbable), End User (Hospitals, ASC), and Region

The global cranial fixation and stabilization systems market is expected to grow at a CAGR of 8.7%. The growth of this market is mainly driven by the increasing prevalence of neurological diseases and high incidence of road accidents and fall related injuries. The cranial fixation and stabilization systems market is highly competitive with the presence of several large as well as emerging players. Prominent players in the cranial fixation and stabilization systems market include B. Braun (Germany), Changzhou Huida (China), DePuy Synthes (US), Evonos (Germany), Integra (US), Jeil Medical (South Korea), KLS Martin (Germany), Medicon (Germany), Medtronic (Ireland), Micromar (Brazil), NEOS Surgery (Spain), OsteoMed (US), Pro Med Instruments (Germany), Stryker (US), and Zimmer Biomet (US).
- Published: March 2018
- Price: $ 4950
- TOC Available:
Arthroscopy Instruments Market by Type (Implants, Arthroscope, Visualization System, Surgical Shaver, RF Ablation, Fluid Management), Application (Knee, Hip, Shoulder), End User (Hospitals, Ambulatory Surgery Centers & Clinics) - Global Forecast to 2022

The global arthroscopy instruments market is projected to reach USD 5.61 Billion by 2022 from USD 4.17 Billion in 2017, at a CAGR of 6.1% during the forecast period. The high incidence of sport-related injuries; technological advancements in arthroscopy products; and efficient reimbursement systems in developed countries are some of the factors driving the growth of the market. The major players of the arthroscopy instruments market are Arthrex (US), Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), Zimmer Biomet (US), CONMED (US), Medtronic (Ireland), Karl Storz (Germany), B. Braun (Germany), Olympus (Japan), Richard Wolf (Germany), MEDICON (Germany), Sklar (US), Millennium (US), and GPC Medical (India).
- Published: February 2018
- Price: $ 4950
- TOC Available:
RSV Diagnostics Market by Product (Kits and Assays, Instruments), Method (Rapid Antigen Detection Test (Immunofluorescence Assay, ELISA), Molecular Diagnostic), End User (Hospitals & Clinics, Clinical Laboratories, Homecare) & Region

The global RSV diagnostics market is expected to grow at a CAGR of 10.1%. Market growth is primarily driven by the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays. Key players in the RSV diagnostics market include bioMérieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg).
- Published: February 2018
- Price: $ 4950
- TOC Available:
Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023

The global embolic protection devices market is projected to reach USD 604.9 Million by 2023, at a CAGR of 8.3%. Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. On the other hand, product failures and recalls may hinder the overall market growth to a certain extent during the forecast period. The prominent players in the embolic protection devices market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US).
- Published: February 2018
- Price: $ 4950
- TOC Available:
Guidewires Market by Material (Nitinol, Stainless Steel, Hybrid), Product (Surgical, Diagnostic (Hydrophilic, Hydrophobic)), Application (Cardiology, Vascular, Neurology, GIT, ENT, Urology, Oncology), End User (Hospital, ASCs) - Global Forecast to 2022

The global guidewires market is projected to reach USD 764.0 Million by 2022 from USD 605.2 Million in 2017, at a CAGR of 4.8%. The growth witnessed by guidewires is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for guidewires across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Abbott (US), Medtronic (Ireland), Terumo (Japan), and Cook Group (US). Other prominent players present in this market include Cardinal Health (US), Olympus (Japan), Johnson & Johnson (US), B. Braun (Germany), C.R. Bard (US), Teleflex (US), and Angiodynamics (US).
- Published: February 2018
- Price: $ 4950
- TOC Available:
Vascular Graft Market by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral Vascular Repair), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End Users (Hospital, Ambulatory Surgery Center) & Region

The global vascular grafts market is expected to grow at a CAGR of 7.3%. Growth in the vascular grafts market is mainly driven by the constant growth in the geriatric population and the corresponding prevalence of aneurysms, increasing incidence of end-stage renal disease, and the growing preference for minimally invasive surgeries. Key players operating in this market are B. Braun (Germany), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US).
- Published: January 2018
- Price: $ 4950
- TOC Available:
Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques (Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application (Epilepsy, Paralysis, Alzheimer’s Disease) & Region

The global neuroprosthetics market is expected to grow at a CAGR of 12.4%. Increasing number of neurological disorders, increasing incidence of hearing loss, increasing prevalence of diabetes, and increasing cases of amputation due to the rising number of accidents & injuries are the major driving factors for this market. Some of the major players operating in the neuroprosthetics market are Boston Scientific (US), LivaNova (UK), Medtronic (US), Abbott (US), Cochlear (Australia), and Second sight (US).
- Published: January 2018
- Price: $ 4950
- TOC Available:
Nerve Monitoring System Market by Product (Nerve Monitor, Electrode, Probe, Accessories), Technology (EEG, EMG, EP, ECOG), Application (Neurosurgery, ENT Surgery, Spine Surgery, Cardiovascular Surgery), End User (Hospital, ASC) - Global Forecasts to 2022

The global nerve monitoring system market is projected to reach USD 1.45 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 4.9% during the forecast period. Increased target patient population, clinical benefits associated with nerve monitoring procedures, and the rising use of nerve monitoring in trauma cases are factors expected to drive the demand for nerve monitoring products during the study period. The major players of the nerve monitoring system market are Medtronic (Ireland), NuVasive (US), Nihon Kohden (Japan), Bovie Medical (US), and Natus Medical (US), Checkpoint Surgical (US), Magstim (UK), Inomed (Germany), Erbe Elektromedizin (Germany), Dr. Langer Medical (Germany), EMS Handels (Austria), Neurovision Medical (US), and Halyard Health (Georgia).
- Published: January 2018
- Price: $ 4950
- TOC Available:
Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) & Geography

The global market for clinical laboratory services is projected to grow at a CAGR of 5.2%. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others
- Published: December 2017
- Price: $ 4950
- TOC Available:
Amniocentesis Needle Market by Type (Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm), Procedure (Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion), End User (Hospitals, Diagnostic Centers, Clinics) - Global Forecast to 2022

The global amniocentesis Needles market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%. Major industry players acquired companies and business units from other companies to maintain and improve their position in the amniocentesis Needles market. Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), and Cook Medical (US) have been identified as the key players in this market.
- Published: December 2017
- Price: $ 4950
- TOC Available:
Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User & Geography

The global kidney function test market is projected to grow at a CAGR of 6.1%. Growth in the kidney function test market can primarily be attributed to factors such as the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, rapid growth in the geriatric population, and the rise in alcohol consumption are driving the growth of the market. The prominent players in the global kidney function/renal function test market are Abbott (US), Siemens (Germany), Sysmex (Japan), Beckman Coulter (US), Roche (Switzerland), ACON Laboratories, Inc. (US), URIT Medical (China), Nova Biomedical (US), ARKRAY (Japan), OPTI Medical (US), 77 Elektronika (Hungary), and Randox Laboratories (UK).
- Published: December 2017
- Price: $ 4950
- TOC Available:
Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) & Geography

The global blood glucose monitoring system market is projected to grow at a CAGR of 4.8%. The key players in the global blood glucose monitoring system market are Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US).
- Published: December 2017
- Price: $ 4950
- TOC Available:
EMS Products Market by Type (Laryngoscope, ET Tube, ECG, Pulse Oximeter, EEG, ICP, TCD, Temperature and Pre-Natal Monitors, Disinfectant, Dressing, Suture, Staple, Wheelchair, Beds), Application (Cardiac, Trauma), End User & Geography

The global EMS products market is projected to grow at a CAGR of 6.1%. The market growth is primarily driven by the high demand for emergency care; increasing incidence of trauma injuries; and growing investments by government bodies on healthcare infrastructure development. Key players in the EMS products market include Stryker (US), Medtronic (Ireland), Asahi Kasei (Japan), Cardinal Health (US), Philips (Netherlands), GE Healthcare (US), Smith & Nephew (UK), 3M (US), Smiths Medical (UK), Becton, Dickinson (US), Johnson & Johnson (US), B. Braun (US), and C. R. Bard (US).
- Published: December 2017
- Price: $ 4950
- TOC Available:
Ophthalmic Surgical Instruments Market by Product (Cataracts (IOL, OVD), Refractive (Femtosecond, Excimer Laser) Glaucoma, Vitreoretinal (Vitrectomy Machine & Packs) Surgical Microscope] End User (Hospital, Specialty Clinic) - Global Forecast to 2022

The global ophthalmic surgical instruments market is expected to reach USD 11.18 Billion by 2022 from USD 7.87 Billion in 2016, at a CAGR of 6.0%. Growth in the global ophthalmic surgical instruments market is mainly driven by factors such as the increasing number of ophthalmic surgeries owing to the growth in geriatric population & related eye diseases, technological advancement in ophthalmic surgical devices, and government initiatives to increase the awareness about visual blindness across the globe. The prominent players in the ophthalmic surgical instruments market are Alcon (Switzerland), Carl Zeiss Meditec (Germany), Johnson & Johnson Vision Care (US), Hoya Corporation (Japan), Bausch + Lomb (US), NIDEK (Japan), Topcon Corporation (Japan), Ellex Medical Lasers (Australia), IRIDEX Corporation (US), Lumenis (Israel), STAAR Surgical Company (US), and Ziemer Ophthalmic Systems (Switzerland).
- Published: November 2017
- Price: $ 4950
- TOC Available:
Blood Warmer Devices/Sample Warmer Market by Sample (Blood, Embryo, Ovum, Semen), End User (Hospital, Blood Bank, Transfusion Center, Tissue Bank), Region (North America, Europe, Asia Pacific) & Geography

The blood warmer devices market is projected to grow at a CAGR of 8.4%. Some of the prominent players in the market are 3M (US), BD (US), The 37Company (Netherlands), Geratherm Medical (Germany), Stryker (US), Sarstedt (Germany), Barkey (Germany), Stihler Electronic (Germany), Belmont instrument (US), Biegler (Austria), and EMIT (US).
- Published: November 2017
- Price: $ 4950
- TOC Available:
Thawing System Market by Type (Manual, Automated), Sample (Blood, Plasma, RBC, Platelets, Whole Blood, Embryo, Semen), End User (Blood Bank, Transfusion Center, Hospital, Tissue Bank, Biotechnology & Pharmaceutical) & Geography

The thawing system market is projected to grow at a CAGR of 12.6%. Factors driving the growth of this market include technological advanced applications of thawing devices, expanding storage capacities of biorepositories, and increasing use of thawed cells in the treatment of cancers and diabetes. Key players in the thawing system market include Helmer Scientific (US), Boekel Scientific (US), Sarstedt (Germany), Barkey (Germany), BioCision (US), Cardinal Health (US), Sartorius (Germany), GE Healthcare (US), Thermo Fisher Scientific (US), and CytoTherm (US).
- Published: November 2017
- Price: $ 4950
- TOC Available:
Atherectomy Devices Market by Product (Directional, Rotational, Laser, Orbital), Application (Peripheral, Cardiovascular, Neurovascular), End User (Hospitals, Surgical Centers, Ascs, Research Laboratories, Academic Institutes) & Geography

The global atherectomy devices market is projected to grow at a CAGR of 6.1%. Factors such as favorable reimbursement scenario for atherectomy procedures, increasing number of research activities in the field of atherectomy, and increasing healthcare expenditure are driving the growth of the market. Major players operating in the market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US). Other prominent players present in this market include Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).
- Published: November 2017
- Price: $ 4950
- TOC Available: